Kyoko Ochiai

Kyoko Ochiai

Auto-generated profile, based on publicly available information

Kyoko Ochiai

Department of Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2018 in Blood Advances
Verified
Journal Article
Open access
PDF file
KOKyoko Ochiai
Kyoko Ochiai
HKHaruka Kondo
Haruka Kondo
YOYasunobu Okamura
Yasunobu Okamura
HSHiroki Shima
Hiroki Shima
YKYuko Kurokochi
Yuko Kurokochi
KIKazuhiko Igarashi
Kazuhiko Igarashi
Key Points: The Ikaros/IRF4 complex represses Ebf1 expression by binding to composite elements within the locus. Ezh2 expression is induced by the Batf/IRF4 complex and the Ebf1-Pax5-Bach2 axis.

1 December 2017 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
TTToru Tamahara
Toru Tamahara
KOKyoko Ochiai
Kyoko Ochiai
AMAkihiko Muto
Akihiko Muto
Yukinari KatoYukinari Kato
Yukinari Kato
NSNicolas Sax
Nicolas Sax
KIKazuhiko Igarashi
Kazuhiko Igarashi
The transcription factor Bach2 regulates both acquired and innate immunity at multiple steps, including antibody class switching and regulatory T cell development in activated B and T cells, respectively. However, little is known about the molecular mechanisms of Bach2 regulation in response to signaling of cytokines and antigen. We show here that mammalian target of rapamycin (mTOR) controls Bach2 along B cell differentiation with two distinct mechanisms in pre-B cells. First, mTOR complex 1 (mTORC1) inhibited accumulation of Bach2 protein in nuclei and reduced its stability. Second, mTOR complex 2 (mTORC2) inhibited FoxO1 to reduce Bach2 mRNA expression. Using expression profiling and chromatin immunoprecipitation assay, the Ccnd3 gene, encoding cyclin D3, was identified as a new direct target of Bach2. A proper cell cycle was lost at pre-B and mature B cell stages in Bach2-deficient mice. Furthermore, AZD8055, an mTOR inhibitor, increased class switch recombination in wild-type mature B cells but not in Bach2-deficient cells. These results suggest that the mTOR-Bach2 cascade regulates proper cell cycle arrest in B cells as well as immunoglobulin gene rearrangement.

1 December 2020 in Cell Reports
Verified
Journal Article
Open access
KOKyoko Ochiai
Kyoko Ochiai
MYMari Yamaoka
Mari Yamaoka
ASAmrutha Swaminathan
Amrutha Swaminathan
HSHiroki Shima
Hiroki Shima
HHHitoshi Hiura
Hitoshi Hiura
KIKazuhiko Igarashi
Kazuhiko Igarashi
The chromatin protein positive coactivator 4 (PC4) has multiple functions, including chromatin compaction. However, its role in immune cells is largely unknown. We show that PC4 orchestrates chromatin structure and gene expression in mature B cells. B-cell-specific PC4-deficient mice show impaired production of antibody upon antigen stimulation. The PC4 complex purified from B cells contains the transcription factors (TFs) IKAROS and IRF4. IKAROS protein is reduced in PC4-deficient mature B cells, resulting in de-repression of their target genes in part by diminished interactions with gene-silencing components. Upon activation, the amount of IRF4 protein is not increased in PC4-deficient B cells, resulting in reduction of plasma cells. Importantly, IRF4 reciprocally induces PC4 expression via a super-enhancer. PC4 knockdown in human B cell lymphoma and myeloma cells reduces IKAROS protein as an anticancer drug, lenalidomide. Our findings establish PC4 as a chromatin regulator of B cells and a possible therapeutic target adjoining IKAROS in B cell malignancies.

11 April 2024 in The EMBO Journal
Verified
Journal Article
Open access
KOKyoko Ochiai
Kyoko Ochiai
HSHiroki Shima
Hiroki Shima
TTToru Tamahara
Toru Tamahara
NSNao Sugie
Nao Sugie
RFRyo Funayama
Ryo Funayama
KIKazuhiko Igarashi
Kazuhiko Igarashi
Transcription factors BACH2 and IRF4 are both essential for antibody class-switch recombination (CSR) in activated B lymphocytes, while they oppositely regulate the differentiation of plasma cells (PCs). Here, we investigated how BACH2 and IRF4 interact during CSR and plasma-cell differentiation. We found that BACH2 organizes heterochromatin formation of target gene loci in mouse splenic B cells, including targets of IRF4 activation such as Aicda , an inducer of CSR, and Prdm1 , a master plasma-cell regulator. Release of these gene loci from heterochromatin in response to B-cell receptor stimulation was coupled to AKT-mTOR pathway activation. In Bach2 -deficient B cells, PC genes’ activation depended on IRF4 protein accumulation, without an increase in Irf4 mRNA. Mechanistically, a PU.1-IRF4 heterodimer in activated B cells promoted BACH2 function by inducing gene expression of Bach2 and Pten , a negative regulator of AKT signaling. Elevated AKT activity in Bach2 -deficient B cells resulted in IRF4 protein accumulation. Thus, BACH2 and IRF4 mutually modulate the activity of each other, and BACH2 inhibits PC differentiation by both the repression of PC genes and the restriction of IRF4 protein accumulation.

10 August 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKatsushi Suzuki
Katsushi Suzuki
MMMitsuyo Matsumoto
Mitsuyo Matsumoto
YKYasutake Katoh
Yasutake Katoh
LLLiang Liu
Liang Liu
KOKyoko Ochiai
Kyoko Ochiai
KIKazuhiko Igarashi
Kazuhiko Igarashi
It has been reported that Bach1-deficient mice show reduced tissue injuries in diverse disease models due to increased expression of heme oxygenase-1 (HO-1)that possesses an antioxidant function. In contrast, we found that Bach1 deficiency in mice exacerbated skeletal muscle injury induced by cardiotoxin. Inhibition of Bach1 expression in C2C12 myoblast cells using RNA interference resulted in reduced proliferation, myotube formation, and myogenin expression compared with control cells. While the expression of HO-1 was increased by Bach1 silencing in C2C12 cells, the reduced myotube formation was not rescued by HO-1 inhibition. Up-regulations of Smad2, Smad3 and FoxO1, known inhibitors of muscle cell differentiation, were observed in Bach1-deficient mice and Bach1-silenced C2C12 cells. Therefore, Bach1 may promote regeneration of muscle by increasing proliferation and differentiation of myoblasts.

27 July 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
梁刘梁 刘
梁 刘
MMMitsuyo Matsumoto
Mitsuyo Matsumoto
MMMiki Matsui-Watanabe
Miki Matsui-Watanabe
KOKyoko Ochiai
Kyoko Ochiai
BCBert Karine K. Callens
Bert Karine K. Callens
KIKazuhiko Igarashi
Kazuhiko Igarashi
BTB and CNC homology 1 (BACH1) represses the expression of genes involved in the metabolism of iron, heme and reactive oxygen species and promotes metastasis of various cancers including pancreatic ductal adenocarcinoma (PDAC). However, it is not clear how BACH1 is regulated in PDAC cells. Knockdown of Tank binding kinase 1 (TBK1) led to reductions of BACH1 mRNA and protein amounts in AsPC−1 human PDAC cells. Gene expression analysis of PDAC cells with knockdown of TBK1 or BACH1 suggested the involvement of TBK1 and BACH1 in the regulation of iron homeostasis. Ferritin mRNA and proteins were both increased upon BACH1 knockdown in AsPC−1 cells. Flow cytometry analysis showed that AsPC−1 cells with BACH1 knockout or knockdown contained lower labile iron than control cells, suggesting that BACH1 increased labile iron by repressing the expression of ferritin genes. We further found that the expression of E-cadherin was upregulated upon the chelation of intracellular iron content. These results suggest that the TBK1-BACH1 pathway promotes cancer cell metastasis by increasing labile iron within cells.